ELISA

Mar 19, 2021

NephroSant Readies Launch of Kidney Transplant Rejection Assay
Premium

Mar 3, 2021

OraSure Technologies Updates Plan for SARS-CoV-2 Antigen Self-Test
Premium

Feb 19, 2021

Irish Research Team Developing Psychosis Prognosis Test
Premium

Feb 11, 2021

Eurofins Gets CE Mark for Coronavirus Antibody Test

Feb 10, 2021

VolitionRx Prices $20M Public Offering

Jan 5, 2021

FDA Grants Emergency Use Authorization for Nirmidas Biotech Point-of-Care Coronavirus Antibody Test

Jan 4, 2021

Studies Demonstrate Use of Gentian Calprotectin Test to Triage COVID-19 Patients
Premium

Dec 15, 2020

Proxim Diagnostics Developing Handheld Analyzer for Point-of-Care, SARS-CoV-2 Testing

Nov 25, 2020

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Nov 9, 2020

GenScript Gets FDA Emergency Use Authorization for Coronavirus Neutralizing Antibody Assay

Nov 3, 2020

New Blood Test Could Identify Pancreatic Cancer Subtypes Responsive to Chemotherapy

Nov 3, 2020

FDA Grants Emergency Use Authorization for Quansys Bio Coronavirus Immunoassay

Oct 29, 2020

Interleukin Biomarkers Could Help Determine Severity of COVID-19, According to New Study

Oct 28, 2020

Biodesix Prices $72M IPO

Oct 23, 2020

FDA Approves Avioq's Supplemental HIV Test

Oct 16, 2020

Proteomics International Inks Italian Distribution Deal for Diabetic Kidney Disease Immunoassay

Aug 27, 2020

SARS-CoV-2 Serology Assay Evaluations Show Seropositivity Increases With Time After Symptom Onset

Aug 10, 2020

BioMérieux, Beijing Wantai Coronavirus Antibody Tests Get FDA Emergency Use Authorization

Jul 1, 2020

ProterixBio Licenses Coronavirus Serology Test From Mass General

Jun 10, 2020

OraSure Awarded $629K BARDA Contract for Saliva-Based SARS-CoV-2 Antibody Test